Abstract
DNA repair proteins are critical to the maintenance of genomic integrity. Specific types of genotoxic factors, including reactive oxygen species generated during normal cellular metabolism or as a result of exposure to exogenous oxidative agents, frequently leads to “ragged” single-strand DNA breaks. The latter exhibits abnormal free DNA ends containing either a 5′-hydroxyl or 3′-phosphate requiring correction by the dual function enzyme, polynucleotide kinase phosphatase (PNKP), before DNA polymerase and ligation reactions can occur to seal the break. Pnkp gene deletion during early murine development leads to lethality; in contrast, the role of PNKP in adult mice is unknown. To investigate the latter, we used an inducible conditional mutagenesis approach to cause global disruption of the Pnkp gene in adult mice. This resulted in a premature aging-like phenotype, characterized by impaired growth of hair follicles, seminiferous tubules, and neural progenitor cell populations. These results point to an important role for PNKP in maintaining the normal growth and survival of these murine progenitor populations.
Introduction
To maintain genomic integrity, DNA damage response (DDR) mechanisms actively recognize and correct up to 70,000 lesions per cell per day (Tubbs & Nussenzweig, 2017). Preserving efficient and competent DDR mechanisms are vital for normal development and tissue maintenance throughout life (Hoeijmakers, 2009). Polynucleotide kinase phosphatase (PNKP) is a bifunctional DNA-processing enzyme active during both single- and double-strand break repair (SSBR and DSBR) (Jilani et al, 1999; Karimi-Busheri et al, 1999; Weinfeld et al, 2011). PNKP is recruited to sites of DNA damage by XRCC1 during base-excision repair and by XRCC4 during nonhomologous end joining (NHEJ) via interactions through its Forkhead-associated domain (FHA) (Koch et al, 2004; Loizou et al, 2004; Bernstein et al, 2005; Aceytuno et al, 2017). Once recruited, the 3′-phosphatase and 5′-kinase domains of PNKP remove either the 3′-phosphate, or phosphorylate the 5′-hydroxyl group, respectively, to prepare the free ends for ligation by either DNA ligase 3 or 4 (Whitehouse et al, 2001; Weinfeld et al, 2011). PNKP is required for SSBR, as well as DSBR via NHEJ (Whitehouse et al, 2001; Shimada et al, 2015; Jiang et al, 2017). In addition, PNKP is also present within mitochondria where it is critical for the repair of oxidative mitochondrial DNA (mtDNA) lesions within these organelles (Mandal et al, 2012; Tahbaz et al, 2012).
In humans, autosomal recessive or compound heterozygous PNKP mutations are responsible for a variety of neurodevelopmental disorders, including microcephaly with early onset seizures and developmental delay (MCSZ) (Shen et al, 2010; Nakashima et al, 2014; Kalasova et al, 2019), a neurodegenerative disease known as recessive ataxia with oculomotor apraxia type 4 (AOA-4) (Bras et al, 2015), and variants of Charcot–Marie–Tooth disease (Pedroso et al, 2015; Leal et al, 2018). Alterations in PNKP expression levels in humans have also been linked to the pathogenesis of spinocerebellar ataxia type 3 (SCA3) in combination with mutant Ataxin-3 (ATXN3) (Chatterjee et al, 2015; Gao et al, 2015). Mutations underlying the neurological disorders are primarily found within the kinase domain of PNKP, although a few have been identified in either the phosphatase or the FHA domains (Shen et al, 2010; Poulton et al, 2013; Nakashima et al, 2014; Kalasova et al, 2019). Despite being clinically distinct diseases, AOA4 and MCSZ mutations are primarily point mutations spread throughout these three domains, with no obvious genotype-to-phenotype correlation (Dumitrache & McKinnon, 2017). Mutations in human PNKP can reduce the stability of the encoded protein, leading to reductions in both the 3′-phosphatase and the 5′-kinase activities and protein levels by as much as 10-fold (Shen et al, 2010; Reynolds et al, 2012).
Studies in mice have demonstrated that global knockout of Pnkp is embryonically lethal, such that conditional inactivation of floxed Pnkp with the Sox2-Cre driver led to death by embryonic day 9 and restricting deletion of floxed Pnkp to neural lineages with the Nestin-Cre driver, led to postnatal death by day 5 (Shimada et al, 2015). These studies highlighted the critical role for Pnkp during development. Furthermore, Shimada et al (2015) carried out elegant comparative studies of both the Nestin-Cre:Pnkpfl/fl mice (between P2 and P5) and the tamoxifen-inducible glial fibrillary acidic protein (GFAP)-CreERT2 driver in Pnkpfl/fl mice. These experiments demonstrated that the loss of Pnkp compromised neuro-progenitor function, as shown by greatly diminished neurogenesis and oligodendrogenesis (Shimada et al, 2015).
Pnkp mutations in humans have been associated with a variety of neurological disease phenotypes, and transgenic mouse model studies have highlighted the neurodevelopmental or neurodegenerative defects that result from Pnkp loss (Shen et al, 2010; Nakashima et al, 2014; Shimada et al, 2015; Dumitrache & McKinnon, 2017; Bermúdez-Guzmán & Leal, 2019; Gatti et al, 2019; Kalasova et al, 2019). The finding that Pnkp mutations interfere with neurodevelopment and CNS function is not unprecedented because various mutations in DDR genes, and especially genes involved in base-excision repair and ssDNA break repair, have been linked to a variety of neurological disorders (Dumitrache & McKinnon, 2017; Jiang et al, 2017). For example, mutations of the gene encoding ligase 4 (Lig4) are a cause of microcephaly (Buck et al, 2006), whereas XRCC1 mutations have been associated with seizures (Hoch et al, 2017). However, the role of PNKP in postnatal brain function still remains poorly understood. Intriguingly, one study linked Pnkp mutations to an early onset neurodegenerative disorder (Poulton et al, 2013), although this was not in keeping with an earlier study (Shen et al, 2010). More recently, mutations in Pnkp have been linked to a Charcot–Marie–Tooth–like disease (“CMT-like”), with age of disease onset in affected individuals in their twenties (Leal et al, 2018).
To gain insight into the functional role of PNKP in the brain as well as other tissues of adult mice, we used the Cre-loxP technology to generate a global Pnkp KO using the 4-hydroxytamoxifen (4-OHT)–inducible ubiquitin C (UBC)-CreERT2 driver. Pnkp deletion was initiated at 3 wk of age, and this led to a progressive age-dependent phenotype in which Pnkp-deficient mice exhibited: (i) alopecia resulting from hair follicle (HF) degeneration followed by progressive hyperpigmentation, (ii) a complete absence of spermatogenesis, and (iii) loss of brain subventricular zone neural progenitors and diminished neurogenesis. In each tissue, Pnkp deficiency was accompanied by evidence of DNA damage (as shown by γH2AX staining) within active progenitor pools, and this was accompanied by dramatically increased levels of cell death within the respective progenitor populations. Thus, our results indicate that normal PNKP function is critical to the survival of progenitors in diverse murine tissues, including skin, testes, and brain.
Results
Generation of mice lacking Pnkp in all tissues
Global or developmental CNS loss of Pnkp is embryonically lethal (Shimada et al, 2015); thus, to investigate the role of Pnkp in postnatal animals we generated mice allowing temporal control over Pnkp deletion via the use of the Cre-loxP technology. To accomplish this, a Pnkpfl/fl transgenic line was developed containing a loxP-flanked (“floxed”) exon 2. Deletion of this exon is predicted to eliminate the FHA domain of PNKP required for functional protein–protein interactions (Koch et al, 2004; Loizou et al, 2004) (Fig 1A–D). Furthermore, if bypass splicing from exon 1 to exon 3 were to occur as a result of exon 2 deletion, this would be predicted to result in a frame-shift followed by an early termination codon (Fig 1A–D). To attain global KO of Pnkp in adult mice we generated UBC-CreERT2:Pnkpfl/fl mice by crossing our Pnkpfl/fl mice with mice expressing the UBC-CreERT2 transgene (Fig 1E). This Cre driver is expressed in all mouse tissues (Ruzankina et al, 2007) and its recombinase activity can be trigged by tamoxifen administration. The resulting mice are designated as Pnkp KOs herein, whereas control mice with genotype Pnkpfl/fl are designated as Pnkp WT.
Similar to the Nestin-Cre x Pnkpfl/fl deletion experiment reported previously (Shimada et al, 2015), we found that interbreeding the Nestin-Cre driver with our Pnkpfl/fl mice resulted in neonatal lethality. Specifically, no viable Nestin-Cre–induced Pnkp KO pups were identified after the birth of 54 pups where the predicted KO frequency was 25%. Furthermore, the 54 births included 11 stillborn pups, of which 4 were confirmed to be Pnkp KOs by genotyping. Last, in a timed-pregnancy pilot experiment, three of nine fetuses taken at 18.5 d gestation were found to be Pnkp KOs. Thus, Nestin-Cre–mediated KO of the floxed Pnkp led to pre- and peri-natal mortality.
To trigger Cre-induced deletions of exon 2 (Fig 1F), UBC-CreERT2:Pnkpfl/fl mice were administered 4-OHT. To confirm loss of PNKP protein in various tissues, we used a rabbit polyclonal anti-PNKP antibody (generated in the laboratory of M Weinfeld) that was raised against the full-length recombinant human PNKP protein, but that also cross-reacts with mouse PNKP. Immunoblotting confirmed the lack of PNKP protein expression in multiple Pnkp KO mouse tissues (Fig 1G and H). Immunostaining of skin, brain and testis tissue sections further demonstrated loss of PNKP protein expression (Fig 1I–K).
As detailed below, deletion of Pnkp exon 2 led to a number of salient phenotypes, including hair loss, hyperpigmentation, failure to gain weight, diminished dermal fat layer, and a complete absence of spermatogenesis (Fig S1A–H). This striking phenotype was not evident in Pnkpfl/fl mice, consistent with these Pnkp alleles not being hypomorphic as a result of the insertion of the loxP sequences flanking exon 2.
Loss of Pnkp leads to a defective HF regeneration cycle
The mammalian HF cycles through stages of active growth (anagen), degeneration (catagen), and quiescence (telogen) to regenerate hair throughout life. This regenerative process is entirely dependent on resident epithelial and mesenchymal stem/progenitor populations that function to supply new cells to the growing HF (Müller-Röver et al, 2001; Stenn & Paus, 2001; Hsu et al, 2014; Morgan, 2014). Within several weeks of Pnkp deletion, mice exhibited hair thinning and by 3 mo marked body hair loss was observed (Figs 1L and M and S1D). To determine whether PNKP plays a role in adult HF-regenerative cycle, age-matched WT and Pnkp KO mice were depilated (plucked) at 2, 5, and 8 mo of age and hair regrowth was then monitored (Fig 2A). Regardless of age, all Pnkp KO mice failed to regrow hair after back skin depilation (n = 5/group/age; Fig 2A). Cross-sectional analysis of Pnkp KO mice skin revealed that HFs underwent a stepwise degeneration, reminiscent of that described for age-related degeneration (Fig 2B) (Matsumura et al, 2016). Representative images of each degenerative stage are shown for Pnkp KO mice. Step 1 is represented by degeneration of the HF mesenchyme, known as the dermal papilla (DP; Fig 2B). Step 2 shows the complete detachment or loss of the DP (Fig 2B), and Step 3 shows the degenerating epithelium, resulting in an atrophic overall HF structure (Fig 2B). The age-related stepwise HF degeneration is thought to be due to progressive stem/progenitor cell loss within the regenerative mini-organ (Matsumura et al, 2016).
Pnkp KO mice accumulate DSBs and show apoptosis within the HF
To investigate whether cells within the HF were undergoing apoptosis or necroptosis, acridine orange staining was used. At a concentration of 50 µM, acridine orange complexes with DNA to emit green wavelengths (∼530 nm) and RNA to emit red wavelengths (∼630 nm) (Fig 2C) (Plemel et al, 2017). In healthy cells, the RNA signal is found within the cytoplasm and nucleus, whereas the DNA signal is restricted to the nucleus. The presence of cells with normal DNA and RNA distribution and signals in Pnkp KO mice suggested that HF degeneration was due to apoptosis rather than to necrosis. We then immunostained WT and Pnkp KO skin sections for cleaved Caspase 3 (CAS3) to detect apoptotic cells, and with γH2AX to detect DSBs. The Pnkp KO mice showed significant increases in the number of CAS3+ve apoptotic cells within the HF (Fig 2D and E), and there was evidence of DSB throughout the HF and interfollicular dermis (Fig 2F and G). Thus, loss of Pnkp resulted in an accumulation of DNA damage within the cells of the HF, and this may have caused apoptosis. Interestingly, cell death was restricted to the HF because CAS3+ve cells were rarely found in the interfollicular dermis (Fig 2D). These results suggested that Pnkp expression was essential to the maintenance of HF progenitor populations.
HFs from Pnkp KO mice often exhibited either an absence of the DP, or DP detachment and displacement from the epithelial compartment. In the Pnkp KO mice, lymphoid enhancer–binding factor 1 (LEF1)+ve DP were observed in ectopic positions in the interfollicular dermis, distant from adjacent HFs (Fig 2H). The DP is a crucial signaling center that modulates transitions in and out of HF regeneration stages. The temporal release of growth factors, including Wnts, transforming growth factors, bone morphogenetic proteins, and fibroblast growth factors, from the DP act to control cell proliferation and differentiation within the HF (Rendl et al, 2008; Greco et al, 2009; Oshimori & Fuchs, 2012). Quantification showed that while 2–5-mo-old WT mice maintained a normal HF structure in all cases (Fig 2I; n = 89 HFs from four mice), the DP was detached in 46.3% of HFs from sex- and age-matched Pnkp KO mice, and a further 29.2% of HFs showed a complete absence of DP (Fig 2I; n = 82 HFs from five mice).
Regeneration of the HF mesenchyme (including the DP) is dependent on mesenchymal progenitors known as HF dermal stem cells (hfDSCs) (Rahmani et al, 2014; González et al, 2017). During telogen phase of the HF regeneration cycle, Integrin α8+ve (ITGA8+ve) hfDSCs can be distinguished from LEF1+ve DP cells (Fig 2J). Within 3 wk after tamoxifen injection, HFs from Pnkp KO mice showed a complete loss of ITGA8+ve hfDSCs (Fig 2J and K). As well, the total number of DP cells that are continually supplemented by hfDSC progeny (Shin et al, 2020) was also diminished (Fig 2B, J, and L; Step 2). The persistence of DP cells in the absence of hfDSCs suggested that Pnkp deficiency first impacts the mesenchymal progenitor pool (hfDSCs), whereas the loss of differentiated DP cells occurs as a secondary event (Fig 2J). Together, our data suggest that PNKP is critical for the maintenance of progenitor cells within the HF, with PNKP deficiency leading to HF degeneration, loss of regenerative capacity, and hence, progressive hair loss.
Next, to investigate whether the loss of Pnkp exclusively in mesenchymal progenitors residing in hair follicles can recapitulate similar phenotypes observed in global Pnkp KO mice, we generated alpha-Smooth muscle actin-CreERT2:RosaeYFP:Pnkpfl/fl transgenic mice (herein referred to as αSMA:Pnkp KO) (Figure S2A). In skin, αSMACreERT2: RosaeYFP effectively labels dermal sheath progenitors that maintain the inductive mesenchyme within hair follicles, as well as vascular smooth muscle cells and arrector pili muscle (Rahmani et al, 2014; González et al, 2017). 4-OHT was administered at the onset of first and second postnatal HF regeneration (Fig S2B) and the mice were tracked until 3 mo (N = 9) or 12 mo (N = 14) of age. Additionally, an identical 4-OHT treatment regime was applied as done to the UBC:Pnkp KO mice (Fig S2C; N = 7). In all experiments, none of the mice exhibited hair loss or hyperpigmentation when examined at 3, 8, or 12 mo of age (Fig S2D and E). Immunofluorescence staining showed YFP+ cells were devoid of the PNKP protein 2 mo after the 4-OHT treatment (Fig S2F), suggesting that self-renewing mesenchymal progenitors can survive in their niche in vivo without functional Pnkp for at least 2 mo. Together, the data suggested that neither 4-OHT administration, nor 4-OHT plus Pnkp deletion, was sufficient to cause depletion of fibroblast progenitors, and furthermore, that depletion of mesenchymal progenitors did not appear to play a role in the hair loss phenotype.
Pigment-containing cells emigrate from the degenerating HF and contribute to ectopic hyperpigmentation within the dermis of Pnkp KO mice
Melanin, synthesized by melanocytes, is stored in large pigment organelles called melanosomes (Slominski et al, 2004, 2005), and in response to ultraviolet light–induced DNA damage, keratinocytes produce factors that stimulate melanin synthesis. In mice, the melanocytes at the base of the hair bulb, which provide melanin to growing hair fibers, can be detected with an antibody against the melanosome protein glycoprotein 100 (GP100) (Fig 3A) (Slominski et al, 2004, 2005). Interestingly, in 2-mo-old Pnkp KO mice, melanin-bearing cells had expanded into the HF epithelium (Fig 3B; Step 1), whereas at later time points (5–8 mo), the melanin-containing cells had spread throughout the entire follicle (Fig 3B; Step 2), and eventually appeared to be emigrating out of the follicle and into the interfollicular dermis (Fig 3B; Step 3). Small dense melanin deposits were observed in Pnkp KO tails (Figs 3C and S1E), whereas much more widespread deposits were found throughout the back dermis of 5–8 mo mice (Figs 1M and 3D). Cells within the latter deposits, found throughout the interfollicular dermis, were positive for GP100 and the keratinocyte marker keratin 14 (KRT14; Fig 3E). This suggested that both melanocytes and keratinocytes were escaping the HF boundary and generating compound aggregates within the Pnkp KO dermis.
To confirm that GP100+ve cells were originating from the HF, we performed an EdU pulse-chase experiment after inducing synchronized hair growth. 2–8 mo-old WT and Pnkp KO mice were depilated to induce entry into anagen, and EdU was then injected i.p. 5 and 6 d after depilation to label proliferating cells. The anagen HFs were then analyzed 10 d post-depilation (Fig 3F). As expected, melanin was restricted to the growing hair fiber during anagen generation in WT mice. However, in Pnkp KO mice, KRT14+ve epithelial cells of the HF were absorbing the melanin as well (Fig 3G). Interestingly, CD200+ve connective tissue sheath cells, along with DP cells were devoid of melanin absorption (Fig 3G). In addition, oddly shaped anagen HF were observed with EdU+ve cells moving out of the HF, suggesting that the structural integrity of the HFs was disrupted. EdU+ve cells were also observed in melanin deposits in the interfollicular dermis (Fig 3H). These findings suggested that after loss of Pnkp, melanocytes and pigmented keratinocytes had migrated away from the follicle structure with retention of their proliferative capacity within the interfollicular dermis.
Pnkp KO testes show a dramatic impairment of spermatogenesis
Given the finding that Pnkp KO testes lacked spermatozoa (Figs 4A and S1F and G), spermatogenesis in these mice was investigated. Spermatogonial stem cells, the initiating cells in spermatogenesis, undergo division to generate progenitor spermatogonia which amplify and subsequently undergo two meiotic divisions to yield spermatids; the latter then repackage their DNA from histones to protamines, undergo considerable morphological changes, and form haploid spermatozoa. Furthermore, spermatogenesis occurs in the long, continuous seminiferous tubules that make up the testis and is supported and regulated by Sertoli cells, which also reside in the tubules, as well as Leydig and other cells types that make up the interstitial space between the tubules (Oatley & Brinster, 2006). To investigate whether this process was impacted in the Pnkp KO mice, testes were collected from mice at 24 h, 7 d, 1, and 5 mo post–4-OHT administration. To avoid 4-OHT-induced DNA damage to spermatogonia at extreme high doses (Sadeghi et al, 2019), 4-OHT treatment was limited to 5 d at 75 mg/kg. Whereas the histology of Pnkp KO testes appeared normal 24 h post–4-OHT, after 1 wk, the seminiferous tubules exhibited disruption, with the remaining germ cells detaching from the seminiferous epithelium (Fig 4A). By 2 mo of age, Pnkp KO seminiferous tubules were devoid of spermatogenesis, and by 5 mo, the tubular architecture was significantly disrupted (Fig 4A), and eventually the testes became atrophic (Fig S1F).
Undifferentiated spermatogonia proliferate but do not differentiate in Pnkp KO mice
Immunostaining of cell type–specific markers within the testis was used to further characterize the spermatogenesis defect in Pnkp KO mice. We observed a few persisting Lin 28 homolog A (LIN28A)+ve germ cells that represent progenitor spermatogonia (Chakraborty et al, 2014); however, no further differentiating germ cells were observed as shown by the absence of meiotic synaptonemal complex protein 3–positive (SYCP3)+ve germ cells (Fig 4B) (Yuan et al, 2000). These rare, persistent germ cells were positive for both glial cell line–derived neurotrophic factor receptor α 1 (GFR⍺1) and the promyelocytic leukaemia zinc finger protein (PLZF) that are established protein markers for undifferentiated spermatogonia (Fig 4C and D) (Buaas et al, 2004; Naughton et al, 2006). These undifferentiated spermatogonia were mitotically active, evident by proliferating cell nuclear antigen expression. We also examined the presence of somatic Sertoli and Leydig cells, which comprise key functional components of the spermatogonial stem cell niche. Vimentin (Vim)-expressing Sertoli, as well as Leydig cells were present in the Pnkp KO testes (Fig 4E). By 5 mo of age, the tubules, which now predominantly comprised Sertoli cells, contained only the occasional cluster of spermatogonia. Thus, similar to our findings in the HF, loss of Pnkp negatively impacts progenitor expansion in the murine testes.
Increased DNA damage and apoptosis in spermatogonial progenitors
To further examine the impact of Pnkp loss in spermatogonia, cultures of these cells, isolated from UBC-CreERT2:Pnkpfl/fl testes, were expanded in vitro. Thus, before treatment with 4-OHT, spermatogonia were isolated from 6–8 d WT and UBC-CreERT2:Pnkpfl/fl mice and cultured for five passages to obtain sufficient cell numbers for experimentation. We found that UBC-CreERT2:Pnkpfl/fl spermatogonia contained significantly fewer cells by 6 d post 4-OHT treatment, as compared with WT 4-OHT–treated or to non-4–OHT treated UBC-CreERT2:Pnkpfl/fl spermatogonia (Fig 4F and G). This decrease in UBC-CreERT2:Pnkpfl/fl cell numbers post-tamoxifen was accompanied by an increased levels of DNA damage (as assessed by γH2AX staining) and the apoptosis marker, cleaved Casp3, despite there being no significant change in their proliferation (Fig 4H).
Next, qPCR was used to assess mRNA expression levels of specific genes in the UBC-CreERT2:Pnkpfl/fl spermatogonia cultures after 4-OHT treatment. Pnkp mRNA was significantly reduced, consistent with Cre-mediated recombination having occured in vitro. Interestingly, there is a higher relative gene expression of undifferentiated spermatogonia associated Id4 in 4-OHT treated UBC-CreERT2:Pnkpfl/fl spermatogonia cultures as compared with tamoxifen-untreated, and tamoxifen-treated WT spermatogonia cultures (Fig 4I). An additional 5 d in culture post–4-OHT led to even further reductions in Pnkp KO spermatogonial cell numbers, and usual colony architecture of the cultures was no longer evident (Fig 4J) along with persistence of the relatively high expression of the undifferentiated spermatogonia associated Id4 gene (Fig 4K). In keeping with the in vivo Pnkp KO testis phenotype of massively impaired spermatogenesis, we found that spermatogonia progenitors in culture rapidly accumulated DNA damage and developed evidence of apoptosis following 4-OHT–triggered induction of Pnkp deletion. Furthermore, treatment of spermatogonial cells with tamoxifen did not lead to an increase in oxidative stress (Fig 4L).
Deletion of Pnkp leads to increased DNA damage within cells within the subventricular zone (SVZ) accompanied by depletion of neural stem cells (NSCs) and their progeny
Prior studies have shown that PNKP mutations lead to neurological abnormalities such as MCSZ in humans, and greatly impaired neurodevelopment in mice, and that Pnkp mRNA is expressed within subventricular progenitor cell populations of both humans and mice (Shen et al, 2010). Based on this, and given the defects observed in response to Pnkp-deficiency in progenitors of skin and testes, we hypothesized that adult neurogenesis in the subventricular zone of the lateral ventricle (V-SVZ) might also be negatively impacted by Pnkp loss.
Postnatal NSCs exist as both quiescent NSCs (qNSCs) and active NSC states (aNSCs). The aNSCs give rise to doublecortin+ve (DCX+ve) neuroblasts that populate the olfactory bulb with new interneurons via the rostal migratory stream. To explore the consequences of Pnkp loss on these cells, both WT and UBC-CreERT2:Pnkpfl/fl mice were treated with 4-OHT at 3 wk of age and then administered EdU for 2 d when they reached 2–8 mo of age (Fig 5A). Immunostaining for γH2AX revealed a marked increase in the number of positive cells in Pnkp KO, versus WT brains (Fig 5B). Evaluation of DCX+ve neuroblasts showed that the number of DCX+ve neuroblasts in the dorsolateral horn was significantly decreased in Pnkp KO brains (Fig 5C and D). Administration of EdU revealed that Pnkp loss resulted in a significant reduction in the numbers of EdU+ve cells per ventricle, as compared with 4-OHT–treated WT mice (Fig 5C and E). To evaluate neural progenitors, we quantified the total number of GFAP+ve SOX2+ve cells (i.e., cells co-expressing GFAP and the SOX2 transcription factor that are essential for maintaining NSCs), along the dorsal horn, lateral wall, and tail of the SVZ from each ventricle in WT and Pnkp KO animals. Again, Pnkp KO brains demonstrated significant reductions in the numbers of GFAP+ve SOX2+ve cells per ventricle (Fig 5F and G). These results support the notion that PNKP deficiency dramatically disrupts NSC maintenance, thus limiting adult neurogenesis.
Pnkp deletion in neural progenitors results in diminished capacity for self-renewal
To evaluate how Pnkp deletion might impact the self-renewal capacity of neural progenitors in vitro, clonally derived neurospheres were generated from the brains of 6–8 d old WT and UBC-CreERT2:Pnkpfl/fl mice. These were passaged twice to enrich for self-renewing stem/progenitors, and then treated with 4-OHT in vitro for 2 d (Fig 5H). Analysis 9 d later revealed that neurospheres grown from Pnkp KO mice were not only significantly smaller in size, but the frequency of spheres per well was also reduced in comparison to 4-OHT–treated WT control cells (Fig 5I–K). Depletion of Pnkp mRNA in the cells of Pnkp KO cultures was confirmed by qPCR (Fig 5L). Congruent with the effects of Pnkp loss on spermatogonial progenitors, we found that neural progenitors were defective in self-renewal and proliferation after induction of Pnkp deletion.
CRISPR-Cas9 induced deletion of PNKP failed to sensitize cultured cells to 4-OHT
.Whether or not loss of PNKP sensitizes cells to 4-OHT induced cytotoxicity remained an important question. To investigate this, PNKP was deleted in the HCT116 colorectal cancer cell line via use of CRISPR-Cas9 (Fig S3A). Control and PNKP KO HCT116 cells were then exposed to increasing concentrations of 4-OHT (including concentrations much higher than those we used in the in vitro experiments on neural and spermatogonial cells) so as to evaluate the potential effect of this agent on HCT116 growth and survival. Crystal violet-based viability assay showed that treatment with 4-OHT did not lead to a preferential decline in the growth of PNKP KO cells, as compared to controls (Fig S3B). Additionally, clonogenic colony forming assays demonstrated that PNKP loss failed to sensitize HCT116 cells to 4-OHT (Fig S3C). In contrast, and as shown by the colony forming assay, PNKP deficiency sensitized the cells to ionizing radiation, an oxidative stress inducer (Fig S3D). These results provided additional support for the idea that PNKP loss does not sensitize cells to potential 4-OHT-induced cytotoxicity.
Discussion
Our results highlight the importance of PNKP in maintaining tissue homeostasis of the post-natal mouse skin, testis, and brain. Indeed, proliferative progenitor cells may be highly susceptible to genotoxic stress and as a result rapidly undergo apoptosis if defective in DNA repair proteins such PNKP. We speculate that this accounts for the impairments in HF cycling, spermatogenesis, and neurogenesis that we have observed. Furthermore, our results suggest that postnatal induction of Pnkp deficiency leads to a progressive degenerative phenotype akin to premature aging. Indeed, stem cell exhaustion or depletion is thought to be one of the factors contributing to the aging process (López-Otín et al, 2013; Vermeij & Hoeijmakers, 2016). Clearly, aging can also be accelerated by the accumulation of nuclear and/or mitochondrial DNA damage, with the latter also having the potential to contribute to the aging process via senescence induction (Vijg & Suh, 2013; Vermeij & Hoeijmakers, 2016).
DNA damage in response to reactive oxygen species (ROS), such as hydrogen peroxide, typically leads to single strand DNA breaks (SSBs), and more rarely to double strand DNA breaks (DSBs). In either scenario, 3′-PO4 and 5′-OH can result from this type of damage, and represent targets for PNKP-mediated repair; hence, loss of PNKP greatly sensitizes cells to ROS-induced DNA damage (Jilani et al, 1999; Rasouli-Nia et al, 2004). Similarly, Epstein–Barr virus–transformed lymphocytes derived from MCSZ individuals showing a substantial decrease in their PNKP protein expression exhibited increased sensitivity to hydrogen peroxide (Shen et al, 2010; Reynolds et al, 2012). Although quiescent stem cells show low intracellular ROS concentrations, the levels of ROS increase and are subject to tight regulation during normal progenitor cell activation, proliferation, and differentiation (Bigarella et al, 2014). Because the repair of ROS-mediated DNA damage is a key function of PNKP, we hypothesize that the progenitor defects we have observed both in vivo and in vitro are due effects of these DNA damaging agents. The γH2AX staining that we have seen in the Pnkp KO cell populations could be the result of persistent ROS-induced dsDNA breaks that result in 3′-PO4 or 5′-OH ends that require repair by PNKP before efficient NHEJ. In addition, inability to correct ROS-induced ssDNA breaks with abnormal termini, would lead to collapse of replication forks during DNA synthesis, triggering apoptosis. Early stages of the latter could also account for γH2AX nuclear staining. It must also be noted that PNKP plays an important role within mitochondria. Thus, its loss also severely impacts mtDNA damage repair given the ROS-rich environment and lack of mtDNA protection by histones (Tahbaz et al, 2012; Bermúdez-Guzmán & Leal, 2019). Defective high-fidelity mtDNA repair could over time lead to increasing mitochondrial dysfunction that would enhance the levels of cellular ROS, in turn leading to increased nuclear as well as mitochondrial DNA damage. A theoretical caveat to explaining the phenotype of the Pnkp KO could be that 4-OHT treatment is known to generate tamoxifen-DNA adducts that would require engagement of DNA repair mechanisms, including nucleotide excision repair (Shibutani et al, 2000; McLuckie et al, 2005), yet the DNA lesions generated in the adduct repair process would not be predicted to be PNKP substrates. More plausibly in view of PNKP function, tamoxifen treatment of breast cancer cells can be associated with induction of oxidative stress (Bekele et al, 2016). However, and as detailed in the Results section, and illustrated by Figs S2 and S3, we found no evidence of 4-OHT-induced oxidative stress, or sensitization of PNKP KO cells to concentrations of this agent that were considerably higher than those used in our neural and spermatogonial in vitro studies. Furthermore, in vivo 4-OHT administration failed to deplete Pnkp-deficient hair follicle mesenchymal progenitors (Fig 2). Together, these results suggest that the phenotype of the Pnkp-null mice was unlikely to be due to 4-OHT-induced oxidative stress, although depending on the specific progenitor compartment examined, this agent may have plausibly played a contributory role. However, Pnkp deletion produced a profound phenotype in the absence of any exogenous 4-OHT. Specifically, a severe neurodevelopmental phenotype associated with widespread neural progenitor cell death, associated with gH2AX- and TUNEL-positivity, was observed after crossing Pnkpfl/flmice with mice expressing Nestin-Cre or Emx1-Cre (Shimada et al, 2015).
A question raised by our study revolves around the differences in the phenotypes stemming from PNKP mutations in humans versus those we observe in Pnkp KO mice. To our knowledge, the human disease phenotypes attributed to mutant PNKP alleles have been confined to the CNS (Shen et al, 2010; Poulton et al, 2013; Bras et al, 2015; Dumitrache & McKinnon, 2017; McKinnon, 2017; Leal et al, 2018; Gatti et al, 2019), or both CNS and PNS (Leal et al, 2018). Because dermatologic disease and/or reproductive defects have not been reported in humans with PNKP mutations, is it possible that the complex multi-tissue Pnkp KO phenotype that we have observed is unique to mice lacking the Pnkp gene? In addition to species-specific differences, other explanations for the apparent discordance may exist. For example, except for one notable exception (Leal et al, 2018), the neurological disorder that dominates the clinical picture in humans, if often recognized in young individuals. Thus, it is plausible that over an entire human lifespan, additional, non-CNS phenotypes will gradually emerge in humans with PNKP mutations. Also, with few exceptions, the disease associated PNKP mutations tend to be the result of point mutations rather than mutations that would be equivalent to the Pnkp KO. In the case of PNKP alleles with small genetic alterations, it is possible that the encoded protein retains some aspect(s) of its function. Indeed, because PNKP mutations can result in reduced protein expression, the levels and functionality of the residual PNKP protein may correlate with the characteristic and severity of the observed phenotype (Shen et al, 2010; Poulton et al, 2013; Bermúdez-Guzmán & Leal, 2019). Thus, PNKP mutations that lead to a major reduction in PNKP protein levels, or mutations that compromise one or more of the key functions of the encoded protein, may lead to severe rapid-onset developmental defects as seen in MCSZ. The converse may be true, as with PNKP mutations that lead to AOA4. It is likely that selection for PNKP mutations capable of preserving some level of normal PNKP function are required for embryonic development and post-natal human viability. Consistent with this idea, our results, and the results of others (Shimada et al, 2015), have demonstrated that early Pnkp deletion is lethal to mice.
Impaired repair of DNA lesions occurring in neural progenitors, as seen with losses of specific DNA repair molecules, can lead to the activation of DNA damage–sensing mechanisms and triggering of apoptosis, as a way to prevent injured progenitors from further proliferation (Gatz et al, 2011; Mckinnon, 2013; Barazzuol et al, 2017). For example, neural progenitors in Lig4 mutant mice were shown to undergo apoptosis in response to very low levels of dsDNA breaks (Gatz et al, 2011). Moreover, losses of many of the known SSB or DSB repair molecules have been proposed to lead to DNA damage and apoptosis in neural progenitor pools (Katyal et al, 2007; Breslin & Caldecott, 2009; Enriquez-Rios et al, 2017). Similarly, we found that loss of Pnkp impacts adult mouse neurogenesis; however, these animals, even aged to 12 mo failed to develop any overt evidence of neurological dysfunction. One reason for this discordance is that PNKP mutations in humans would be predicted to exert their effects during vulnerable times of embryonic, fetal, and/or post-natal brain development, with this determine the severity of the resulting neurological phenotype. This contrasts with our mouse model wherein Pnkp deletions were triggered post-weaning, presumably attenuating the impact of Pnkp deficiency on neurodevelopment. Thus, in contrast to loss of Pnkp during early brain development, the neurological phenotype, if any, resulting from impaired neurogenesis in adult Pnkp KO mice appears to be subtle. However, it is possible that a neurological defect(s) may emerge with further aging.
We found that adult neurogenesis was greatly impaired in Pnkp KO mice, and this was accompanied by in vivo evidence of DNA damage as shown by γH2AX staining of SVZ cell populations. This observation was also supported by our finding that induction of Pnkp deletion in NSC cultures caused a rapid inhibition of cell proliferation and self-renewal. In terms of the underlying pathogenetic mechanism(s) stemming from Pnkp loss, it seems plausible that our findings in adult mice mirror the neural cell progenitor damage resulting from Pnkp deficiency during early development.
We have focused much of the discussion on neural progenitors because neurological impairment is the predominant phenotypic feature of human PNKP mutations. However, in the Pnkp KO mouse we found two other progenitor cell populations that were also severely compromised, those required for normal HF growth and for spermatogenesis. The discovery that progenitors in these unrelated cell populations were negatively impacted by Pnkp loss, raises the possibility that other progenitor populations might be similarly affected, including hematopoietic progenitors and cells involved in regenerating the gut epithelium. If this proved correct, then it would indicate that one of the key functions of PNKP is to maintain the integrity of progenitor cell populations.
Materials and Methods
Mouse handling and ethics
Mouse maintenance and experimentation was carried out with ethics approval from the University of Calgary’s Animal Care Committee and in accordance with the regulations of the Canadian Council on Animal Care.
Generation of floxed Pnkp mice
Transgenic mice were generated in the University of Calgary’s Clara Christie Centre for Mouse Genomics. To introduce loxP sites into the Pnkp allele, a pair of RNA Zn finger nucleases (ZFN) (designed by Sigma-Aldrich) were used in combination with a targeting donor vector that included an Frt-flanked Pgk-NeoR selection cassette, and a loxP-flanked Pnkp exon 2 sequence with 800 bp homology arms on either side (based on C57BL/6 sequences). The ZFN cut site was: ACCCCTGTCATCCAGagaatTGGGTGGTAGAGGCATGAG. The targeting donor vector was synthesized (Celtek), transformed into Stbl2 competent cells (10268019; Thermo Fisher Scientific), grown in Luria broth (244620; BD Difco) with 100 μg/ml Ampicillin (A9518; Sigma-Aldrich), and purified with the PureLink HiPure Plasmid Midiprep Kit (K210015; Thermo Fisher Scientific).
G4 (129 x C57BL/6 F1) hybrid embryonic stem cells (ES) (George et al, 2007) were transfected by electroporation with the mRNAs encoding the ZFNs along with the donor vector. Targeted cells were placed under G418 selection (15750060; Thermo Fisher Scientific) at a concentration of 275 μg/ml. Surviving clones were picked, expanded, and analyzed by 5′ and 3′ PCR to verify the correct site integration. Positive ES clones were assessed for aneuploidy via metaphase spread preps. Highly (>75%) euploid lines were either aggregated or microinjected into CD1E WT embryos to generate chimeric mice. Both aggregation and microinjection protocols produced chimeric mice with successful germline transmission of the targeted Pnkp allele. Mice showing germline transmission stemming from an aggregation chimera were then bred with the ROSA26-FLPe mouse (JAX Stock No. 009086) to excise the Pgk-NeoR selection cassette. Mice were then backcrossed for >10 generations on to the C57BL/6J background. Crossing heterozygous mice together produced homozygous “floxed” Pnkpfl/fl (exon2) mice. After crossing the Pnkpfl/fl with a Cre driver line, mice were genotyped using the KAPA HotStart Mouse Genotyping Kit (Ref # KK7352; Sigma-Aldrich) and Pnkp’HomoF 5′-GACAAGTCCGTGTCTCTAGCAATC 3′ and Pnkp3′HomoR 5′-TCCCACCTATTCACTTCGTGTG 3′ primers. The floxed band was 664 bp, the KO band was 247 bp, and the WT band was 551 bp. PCR cycling program was set to 95°C × 3 min (95°C × 15 s, 60°C × 15 s, 72°C × 30 s) for 35 cycles, then 72°C × 5 min, 4°C hold.
Conditional deletion of the Pnkp
To obtain post-natal gene deletions, Pnkpfl/fl mice were interbred with mice expressing UBC-CreERT2 (JAX Stock No. 007001 on a C57BL/6J background) to cause Pnkp exon 2 loss in all tissues following tamoxifen administration. All experimental and control mice were administered intraperitoneal injections of 75 mg/kg 4-OHT in sunflower oil every 24 h for five consecutive days, beginning at 3 wk of age. The experimental mice were of the genotype UBC-CreERT2:Pnkpfl/fl that were administered 4-OHT, and controls were of the genotypes of UBC-CreERT2:Pnkpfl/fl (minus 4-OHT), WT, and either UBC-CreERT2 (plus 4-OHT) or Pnkpfl/fl (plus 4-OHT). All mice were weighed at the time of injection to ensure consistent dosing. Pnkpfl/fl mice were also interbred with transgenic mice that expressed Nestin-Cre (JAX Stock No. 003771 on a C57BL/6J background).
Immunohistochemistry
Brain and skin
Animals were euthanized with perfused with 4% PFA in PBS (0.2 mM and pH 7.4) before surgically removing the brain and skin. Removed brains were stored in 4% PFA overnight before being transferred into 30% sucrose in PBS overnight. Back skin biopsies were fixed with 2% PFA in PBS overnight, washed 3× in PBS and treated in 10%, 20%, and 30% sucrose in PBS overnight. Prepared biopsies were snap-frozen in Clear Frozen Section Compound (VWR International). Frozen tissue blocks were sectioned using a Leica 3050s cryostat with sections loaded onto Superfrost plus slides (Thermo Fisher Scientific) and stored at −80°C. Whole-mount brains were cut along the rostral-caudal axis in coronal sections at 15 μm thickness. The analyzed sections were contained within a rostral-caudal section of 1,200 μm, beginning at the most caudal point where the SVZ is clearly visible. Back skin samples were cut along the sagittal plane at 45 μm thickness. Frozen tissue sections were rehydrated, then blocked with 10% normal serum containing 0.5% Triton X-100 for 1 h. Primary antibodies were incubated overnight at 4°C, washed 3× with PBS and then incubated with Alexa Fluor secondary antibodies (Invitrogen) at 1:1,000 for 1 h. After 1× PBS wash, sections were stained with 1 mg/ml of Hoechst 33258 (Thermo Fisher Scientific) for 20 min and washed again 3× in PBS before covering with Permafluor (Thermo Fisher Scientific) and a cover slip. High-resolution imaging was performed with the SP8 spectral confocal microscope (Leica). Image editing was performed using Adobe Photoshop, Adobe Illustrator and LASX software (Leica). The list of antibodies used can be found in “Antibodies Table.”
Testes
Testes were fixed in 4% PFA in PBS and paraffin embedded. Immunohistochemistry was performed on 5 µm sections using primary antibodies listed in “Antibodies Table” and species appropriate secondary antibodies.
In vivo depilation and EdU pulse-chase
Pnkp KO mice at 2, 5, and 8 mo of age were depilated using wax strips. To label proliferating cells, 5-ethynyl-2′-deoxyuridine (EdU) in PBS (50 mg/kg) was administered via intraperitoneal injections for 2 d, and an 8-mm skin punch biopsy was harvested 3 d after injection and the brain 20 d after injection. Before tissue collection, mice were euthanized with an overdose of sodium pentobarbital and transcardially perfused with 20 ml of PBS followed by 20 ml of cold 4% PFA. The dissected brains were post-fixed overnight in 4% PFA at 4°C and allowed to equilibrate overnight in 30% sucrose at 4°C. The brains were then embedded in cryoprotectant (VWR Clear Frozen Section Compound) for storage at −80°C. The SVZ was cut along the rostral-caudal axis in coronal sections (15 μm) using a cryostat (Leica). The analyzed sections were contained within a rostral-caudal section of 1,200 μm, beginning at the most caudal point where the SVZ is clearly visible. The sections were stored at −80°C until further use. EdU staining was performed using a Click-iT EdU Alexa Fluor 555 kit, according to the manufacturer’s instructions. Nuclear staining was subsequently performed using Hoechst-33258 (1:100), and the sections were mounted using Permafluor mountant. Sections were imaged for quantification using a Leica SP8 confocal microscope (20× objective, 1.00 μm z-stacks), and representative images were taken using a Leica SP8 confocal microscope (20× objective and 63× objective).
Neurosphere culture
Whole brains of postnatal day six (P6) UBC-CreERT2:Pnkpfl/fl mice were isolated and cut in a sagittal direction down the primary sulcus between the two hemispheres to expose the lateral ventricles. Dissection of the lateral ventricles from the brains of WT (n = 4 animals) and Pnkp KO (n = 8 animals) was subsequently performed. The lateral ventricles were minced using a scalpel, then dissociated to single cells in 37°C TrypLE (Thermo Fisher Scientific) with trituration using a P200 pipette for no longer than 10 min. Neutralization of the TrypLE occured with the addition of 3:1 DMEM:F12 (Thermo Fisher Scientific). The cells were centrifuged at 210g for 5 min and the supernatant removed. Pellets were resuspended in 3:1 DMEM (Thermo Fisher Scientific) to F12 (Thermo Fisher Scientific), filtered through a 40-μm filter, then centrifuged at 280g for 5 min and the supernatant removed. The pellets were resuspended and seeded in growth media (3:1 DMEM to F12 cell culture media, with additives bFGF [50 ng/ml; Peprotech], EGF [200 ng/ml; Peprotech], B27 supplement [4%; Life Technologies], penicillin/streptomycin [2%; StemCell Technologies] and fungizone [0.4%; Thermo Fisher Scientific]) at a concentration of 100,000 cells/ml. Cells were fed every 3 d with fresh cell culture media and grown for 8–9 d at 37°C in 5% CO2 before passaging. Cells were passaged twice before experimentation. Passaged NSCs were plated in six-well plates in growth media at a density of 10,000 cells/ml and treated with 0.2 µM 4-OHT before analysis at 9 d after the second passage. Neurospheres were counted and imaged to measure their mean diameters in each well.
Spermatogonial culture
Spermatogonia were isolated from 6- to 8-d-old pup testis by magnetic assisted cell sorting using a Thy1.2 (CD90.2) rat anti-mouse antibody and cultured as previously described (Yeh et al, 2007). To generate Pnkpfl/fl deletions in spermatogonia cultures, 0.2 µM 4-OHT was used; with the latter showing no effect on control spermatogonial viability or cell numbers. Spermatogonia were cultured on STO feeder cells as previously described (Yeh et al, 2007) for the first five passages to establish the cultures and then passaged onto 1:10 reduced factor Matrigel-coated wells before treatment in order to reduce the number of feeder cells in the cultures. Cells were treated on day 3 in culture and collected or passaged on day 6. For extended culture experiments, a second 4-OHT treatment was added on day 7 (1 d after passage) and cells were then collected on day 11. Cells were seeded at a density of 2.0 × 105 cells/ml in 12- or 24-well plates.
Flow cytometry
Cultured spermatogonia were fixed in 4% PFA and probed with the following primary antibodies and appropriate species-specific secondary antibodies: CASP3 at a 1:800 dilution and γH2AX at a 1:800 dilution (both were rabbit monoclonal antibodies from Cell Signaling Technologies). Rabbit IgG isotype controls were used for gating. Proliferation was measured using EdU incorporation (1 mg/ml) which was added to cell culture medium for 6 h before collection and staining according to the manufacturer’s instructions (Click-iT EdU; Invitrogen). Cells were analyzed using a BD FACSCalibur.
Quantitative PCR
RNA was isolated from pelleted cells using QIAGEN RNeasy Mini Kit followed by reverse transcription using ABI High Capacity cDNA Synthesis kit according to the manufacturer’s instructions. cDNA samples were amplified using Bio-Rad SosoFast EvaGreen master mix and gene specific primers as follows: Pnkp forward 5′-TTC AGG TGC TGG TGG CAA CA-3′ reverse 5′-CTG CTG CAT CTC CCA CGA AGA C-3′, Id4 forward 5′-ACT CAC CGC GCT CAA CAC T-3′ reverse 5′-GCA CAC CTG GCC ATC CAT-3′, Gfr⍺1 forward 5′-AGA GCC TGC AGG AAA TGA CCT ACT-3′ reverse 5′-GCA TCG AGG CAG TTG TTC CCT T-3′, Sohlh1 forward 5′-GGA TGC AGC AAG ACT CCT CAG C-3′ reverse 5′-CTG ACC ACG TTT CTC CGA AGA CTG-3′, cKit forward 5′-CCT CAG CCT CAG CAC ATA GC-3′ reverse 5′-CTG GCG TTC ATA ATT GAA GTC ACC-3′ and Hprt1 forward 5′-AGC AGT ACA GCC CCA AAA TGG T-3′ reverse 5′-CCA ACA AAG TCT GGC CTG TAT CC-3′. Samples were run on an ABI 7500 Fast qPCR and relative fold change was calculated using ∆∆CT relative to housekeeping gene Hprt1.
CellROX flow cytometry methods
Oxidative stress was measures using CellROX (Invitrogen) according to the manufacturer’s instructions. Briefly, 5 μM of CellROX Green Reagent was added to spermatogonia cell cultures and incubated at 37°C for 30 min, wells were washed three times with PBS, and fixed in 4% formaldehyde for 15 min. Spermatogonia cells were then analyzed using a BD FACSCalibur and FlowJo software.
Immunoblotting
Lysates were prepared from control and PNKP KO HCT116 cells (Chalasani et al, 2018) in RIPA buffer (Cat. no. 89900; Thermo Fisher Scientific). Then, 30 μg of protein was loaded onto each lane of a 10% resolving gel and then transferred onto nitrocellulose membrane (Cat. no. 1620115; Bio-Rad Laboratories) using the Trans-Blot Turbo transfer system (Bio-Rad Laboratories). The membrane was blocked with 5% milk in 1× TBST buffer for 1 h at room temperature, and then it was cut into three pieces for immunoblotting for PNKP, with b-actin and XPF serving as loading controls. Primary antibodies (anti-PNKP, 1:1,000, dilution, sc-365724; Santa Cruz; anti-β-Actin – 1:3,000, sc-47778; Santa Cruz; anti-XPF, 1:1,000 dilution, MA5-12060; Thermo Fisher Scientific) were prepared in 5% milk in 1× TBST buffer and the membranes were incubated overnight at 4°C. Membranes were then washed 3× in 1× TBST followed by a 1 h incubation with the secondary antibody (HRP goat anti-mouse IgG, dilution 1:3,000, 926-80010; LI-COR) at room temperature. After three washes in 1× TBST, Super Signal West Pico Plus Chemiluminescent Substrate (Cat. no. 34577; Thermo Fisher Scientific) was applied prior to examination using an Odyssey scanner (LI-COR). Images were processed and quantified using Image Studio (Ver. 5.2; LI-COR).
Crystal violet assay
Wells in a 96-well plate were seeded with 3,000 cells per well and incubated overnight to allow cell attachment. Serial dilutions of a 10 mM (in 100% ethanol) stock solution of 4-OHT (H7904; Sigma-Aldrich) were prepared in cell culture media and added to the plates. A crystal violet based assay was performed after a 72-h exposure to 4-OHT. Following exposure to the drug, the media was discarded, attached cells were stained with 0.5% crystal violet (Sigma-Aldrich) for 20 min at room temperature, washed three times with distilled water and allowed to air-dry. Crystal violet stained cells were shaken for 20 min in 200 μl of methanol and the OD was measured at 570 nm using a FLUOstar OPTIMA microplate reader (BMG Labtech). Percent cell survival was calculated by subtracting the OD of blank wells and then normalizing DMSO controls to 100%. Data were plotted using GraphPad Prism 5.04 (GraphPad Software).
Colony forming assay
Between 200 and 3,000 control and PNKP KO HCT116 cells were seeded in 60-mm petri dishes and incubated overnight to allow attachment. On day 2, cells were exposed to various concentrations of 4-OHT (10 mM stock in ethanol, diluted in culture media). After 9 d incubation, colonies were fixed, stained and counted. To measure their sensitivity to ionizing radiation, cells were irradiated with 60Co g-radiation using a Gamma Cell Irradiator (Atomic Energy of Canada Ltd.) using the following doses: 0, 1, 2, 4, 6, and 8 Gy. After 9 d incubation, colonies were fixed, stained and counted. Data were plotted using GraphPad Prism 5.04.
Statistics
Quantification of immunohistochemistry sections was performed by an evaluator blinded as to the identities of the samples. Quantitative data were represented as means with SD. Independent samples t tests and two-way ANOVA were performed according to statistical guidelines in SPSS Statistics 24. Significance was set at P < 0.05.
Data Availability
No data to be disclosed.
Acknowledgements
We are grateful to Cameron Fielding the University of Calgary Centre for Genome Engineering in the Clara Christie Centre for Mouse Genomics for generating the ‘floxed’ Pnkp transgenic line. We also thank Dragana Ponjevic for her assistance in preparing some of the tissue samples for histological analysis. Funding that enabled purchase of the Zn finger nucleases used in this study was kindly provided by the Cumming School of Medicine Centre for Advanced Technologies. This work was supported by grants from the Canadian Institutes of Health Research (J Biernaskie, PJT159487; FR Jirik, MOP342685; M Weinfeld, PJT168869).
Author Contributions
W Shin: formal analysis, validation, investigation, methodology, and writing—original draft, review, and editing.
W Alpaugh: formal analysis, validation, investigation, methodology, and writing—original draft.
L Hallihan: resources and methodology.
S Sinha: validation, investigation, and methodology.
E Crowther: validation, investigation, and methodology.
GR Martin: investigation and methodology.
T Scheidl-Yee: investigation and methodology.
X Yang: formal analysis and investigation.
G Yoon: validation, investigation, and methodology.
T Goldsmith: validation.
ND Berger: validation and writing—review and editing.
LGN de Almeida: investigation.
A Dufour: investigation and methodology.
I Dobrinski: conceptualization, supervision, project administration, and writing—review and editing.
M Weinfeld: conceptualization, supervision, funding acquisition, project administration, and writing—review and editing.
FR Jirik: conceptualization, supervision, funding acquisition, project administration, and writing—original draft, review, and editing.
J Biernaskie: conceptualization, supervision, funding acquisition, project administration, and writing—review and editing.
Conflict of Interest Statement
The authors declare that they have no conflict of interest.
- Received May 21, 2020.
- Revision received June 22, 2021.
- Accepted June 23, 2021.
- © 2021 Shin et al.
This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).